Sex-Specific Associations of Monocyte-Based Inflammatory Indices with Renal Dysfunction and Hyperuricemia in the

Hamood AlSudais1, Dalal Alsowaida1, Rehab B Albakr2

  • 1Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, King Saud University, Riyadh 12372, Saudi Arabia.

Insights

The monocyte-to-high-density lipoprotein cholesterol ratio (MHR) is a key indicator for kidney dysfunction and high uric acid levels. This simple marker shows significant sex-specific differences in risk assessment for the Saudi population.

Area of Science:

  • Nephrology
  • Clinical Biochemistry
  • Epidemiology

Background:

  • Chronic kidney disease (CKD) presents a significant global health challenge, often linked to chronic inflammation.
  • Monocyte-based inflammatory indices like MHR, MLR, and MNR are implicated in metabolic and inflammatory conditions.
  • The specific associations of these indices with renal dysfunction and hyperuricemia, particularly sex-specific variations, require further investigation.

Purpose of the Study:

  • To investigate the relationship between monocyte-to-high-density lipoprotein cholesterol ratio (MHR), monocyte-to-lymphocyte ratio (MLR), and monocyte-to-neutrophil ratio (MNR) with renal dysfunction and hyperuricemia.
  • To explore potential sex-specific differences in these associations within the Saudi general population.

Main Methods:

  • A retrospective cross-sectional study involving 9657 Saudi adults.
  • Calculation of estimated glomerular filtration rate (eGFR) using the 2021 CKD-EPI equation.
  • Sex-stratified analysis including correlation, risk assessment, ROC analysis, and regression modeling to examine associations.

Main Results:

  • The monocyte-to-high-density lipoprotein cholesterol ratio (MHR) emerged as the most robust marker for renal dysfunction.
  • Significant sex-specific differences were observed: higher MHR and MLR correlated with reduced eGFR in females, while lower MHR, MLR, and MNR correlated with reduced eGFR in males.
  • MHR demonstrated the strongest association with hyperuricemia in both sexes and maintained an independent inverse relationship with eGFR.

Conclusions:

  • MHR is a consistent and valuable index for assessing renal dysfunction and hyperuricemia.
  • The findings highlight the importance of considering sex-specific differences when utilizing MHR for risk assessment.
  • MHR offers a simple, accessible biomarker for sex-informed renal and metabolic risk evaluation in the general population.

Related Concept Videos